We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Castle Biosciences Inc | NASDAQ:CSTL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.82 | 3.72% | 22.84 | 23.00 | 24.49 | 23.19 | 21.7379 | 22.14 | 322,974 | 00:59:59 |
|
UNITED STATES
|
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
|
Washington, D.C. 20549
|
|
|
|
|
☐
|
Rule 13d-1(b)
|
☐
|
Rule 13d-1(c)
|
☒
|
Rule 13d-1(d)
|
CUSIP No. 1483C-105
|
13G
|
Page 2 of 5 Pages
|
|
1
|
Names of Reporting Persons
Derek J. Maetzold |
|||
|
|||||
|
2
|
Check the Appropriate Box if a Member of a Group
|
|||
|
|
(a)
|
☐
|
||
|
|
(b)
|
☐
|
||
|
|||||
|
3
|
SEC Use Only
|
|||
|
|||||
|
4
|
Citizenship or Place of Organization
United States of America |
|||
Number of
Shares Beneficially Owned by Each Reporting Person With: |
5
|
Sole Voting Power
1,953,215 Shares (1) |
|||
|
|||||
6
|
Shared Voting Power
0 Shares |
||||
|
|||||
7
|
Sole Dispositive Power
1,953,215 Shares (1) |
||||
|
|||||
8
|
Shared Dispositive Power
0 Shares |
||||
|
|||||
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,953,215 Shares |
|||
|
|||||
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares ☐
|
|||
|
|||||
|
11
|
Percent of Class Represented by Amount in Row (9)
11.3% (2) |
|||
|
|||||
|
12
|
Type of Reporting Person
IN |
|||
CUSIP No. 1483C-105
|
13G
|
Page 3 of 5 Pages
|
Item 1(a).
|
|
Name of Issuer:
Castle Biosciences, Inc. |
Item 1(b).
|
|
Address of Issuer’s Principal Executive Offices:
820 S. Friendswood Drive, Suite 201
Friendswood, TX 77546
|
Item 2(a).
|
|
Names of Persons Filing:
Derek J. Maetzold |
Item 2(b).
|
|
Address of Principal Business Office, or, if none, Residence:
820 S. Friendswood Drive, Suite 201
Friendswood, TX 77546
|
Item 2(c).
|
|
Citizenship:
United States of America
|
Item 2(d).
|
|
Title of Class of Securities:
Common Stock |
Item 2(e).
|
|
CUSIP No.:
14843C 105 |
Item 3.
|
|
Not Applicable.
|
Item 4.
|
Ownership
|
(a)
|
Amount beneficially owned
|
|
See Row 9 of cover page.
|
(b)
|
Percent of Class:
|
|
See Row 11 of cover page.
|
(c)
|
Number of shares as to which such person has:
|
(i) Sole power to vote or to direct the vote: See Row 5 of cover page.
|
(ii) Shared power to vote or to direct the vote: See Row 6 of cover page.
|
(iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page.
|
(iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed to report the fact that as of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the
following: ☐
|
|
|
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Not applicable
|
CUSIP No. 1483C-105
|
13G
|
Page 4 of 5 Pages
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
|
Not applicable
|
|
|
|
Item 8.
|
Identification and Classification of Members of the Group
|
Not applicable
|
|
|
|
Item 9.
|
Notice of Dissolution of Group
|
Not applicable
|
CUSIP No. 1483C-105
|
13G
|
Page 5 of 5 Pages
|
Item 10.
|
Certifications
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired
and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose
or effect.
|
|
/s/ Derek J. Maetzold
|
|
Derek J. Maetzold
|
1 Year Castle Biosciences Chart |
1 Month Castle Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions